切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2021, Vol. 11 ›› Issue (06) : 339 -345. doi: 10.3877/cma.j.issn.2095-2007.2021.06.004

论著

筛选睑板腺功能障碍诊断参数建立诊断模型的临床研究
杜娟1, 韦振宇2, 梁庆丰2,()   
  1. 1. 100730 首都医科大学附属北京同仁医院预防保健科
    2. 北京同仁眼科中心 北京市眼科研究所 北京市眼科学与视觉科学重点实验室
  • 收稿日期:2021-05-08 出版日期:2021-12-28
  • 通信作者: 梁庆丰
  • 基金资助:
    国家自然科学基金(81470607); 北航-首医大精准医疗高精尖创新中心同仁分中心开放基金(BHTR-KFJJ-202003); 北京市科委医药协同重点专项(Z181100001918031)

Screening of diagnostic parameters and establishment of diagnostic model for meibomian gland dysfunction

Juan Du1, Zhenyu Wei2, Qingfeng Liang2,()   

  1. 1. Department of Preventive Health Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
    2. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Science Key Lab., Beijing Institute of Ophthalmology, Beijing 100730, China
  • Received:2021-05-08 Published:2021-12-28
  • Corresponding author: Qingfeng Liang
引用本文:

杜娟, 韦振宇, 梁庆丰. 筛选睑板腺功能障碍诊断参数建立诊断模型的临床研究[J]. 中华眼科医学杂志(电子版), 2021, 11(06): 339-345.

Juan Du, Zhenyu Wei, Qingfeng Liang. Screening of diagnostic parameters and establishment of diagnostic model for meibomian gland dysfunction[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2021, 11(06): 339-345.

目的

筛选对睑板腺功能障碍(MGD)诊断有价值的特征性指标并建立诊断模型。

方法

收集2016年3月至11月由首都医科大学附属北京同仁医院眼科中心、北京市眼科研究所、陕西省西安市第一医院、中国医学科学院北京协和医院及暨南大学附属第一医院等23家多中心医疗单位眼科门诊连续观察的MGD患者923例(923只眼)和健康志愿者114例(114只眼)。其中,男性353例(353只眼),女性684例(684只眼);年龄18~88岁,平均年龄(42.5±13.9)岁。通过问卷调查收集人口学信息,自我评估眼表疾病评分指数(OSDI);检查所有患者右眼的泪膜破裂时间(TBUT)、角结膜荧光素染色评分、泪液分泌测试(SchirmerⅠ)、睑板腺红外照相、泪膜脂质层厚度(LLT)、睑板腺开口及分泌物性状评分。采用数字表法随机将所有患者拆分为70%模型组和30%验证组。按照临床诊断,判定70%模型组中MGD患者和健康者各指标诊断的阴阳性结果,数据以例数和百分比表示,组间的比较采用卡方检验。采用工作特征曲线(ROC)分析获得曲线下面积(AUC)验证MGD各检测指标的诊断效能,并将有效指标通过Logistic回归模型建立判别模型。而后使用30%验证组MGD患者及健康者进行判别,以验证诊断模型的有效性。

结果

在70%模型组中,MGD患者与健康者女性分别为402例和91例,分别占62.2%和79.8%,两组性别比较的差异有统计学意义(χ2=196.189,P<0.05)。70%模型组中MGD患者OSDI评分、角结膜荧光素染色、SchirmerⅠ值试验、睑板腺缺失率、LLT、睑板腺腺体开口数量、睑板腺睑脂评分及TBUT与临床诊断结果一致者分别为478例、180例、492例、604例、512例、504例、575例及583例,分别占74.0%、27.9%、76.2%、93.5%、79.4%、78.0%、89.0%及90.4%。两组比较的差异均有统计学意义(χ2=44.46,442.54,25.20,17.54,12.52,6.91,13.90,1.75;P<0.05)。经ROC曲线分析,尽管OSDI评分、角结膜荧光素染色、睑板腺腺体开口数量、睑板腺睑脂评分及TBUT诊断的AUC均小于0.800(P<0.05),但当将性别(X1)、OSDI评分(X2)、角结膜荧光素染色评分(X3)、TBUT(X4)、睑板腺腺体开口数量(X5)及睑板腺睑脂评分(X6)有诊断价值的6项指标联合采用多元Logistic回归模型建立MGD诊断判别模型时,AUC能达到0.800,说明此模型的诊断效果已达到良好的标准。公式为Y=1/(1+e-Z),Z=-4.546+1.069X1-0.020X2+0.286X3-0.553X4-0.220X5+0.124X6。当Y<0.196时,判别模型MGD诊断的敏感度为83.4%,特异度为61.4%。将30%验证组的数据在判别模型中进行分类判别。两组与临床诊断一致者分别为229例和44例,分别占82.7%和40.6%,两组比较的差异无统计学意义(χ2=0.17,P>0.05)。敏感度为82.7%,特异度为61.4%。

结论

性别、OSDI评分、睑板腺腺体开口数量、睑板腺睑脂评分、TBUT及角结膜上皮荧光素染色有助于MGD诊断,基于这些指标建立的Logistic判别模型有较高的灵敏度和特异度。

Objective

The aim of this study was to select the characteristic indicators for the diag-nosis of meibomian gland dysfunction (MGD) and establish a model to diagnose MGD.

Methods

From March to November 2016, 923 MGD (923 eyes) and 114 cases of healthy volunteers (114 eyes) were collected in 23 multi-center medical institutions including Beijing Tongren Hospital, affiliated to the Capital Medical University, Beijing Institute of Ophthalmology, The First Hospital of Xi′an Shaanxi Province, Chinese Academy of Medical Sciences and the First Hospital affiliated to Jinan University. Among of them, there were 330 male (eyes) and 684 female (684 eyes) with an average age (42.5±13.9) years-old (ranged from 18 to 88 years-old). Demographic information and self-assessment of ocular surface disease index(OSDI) were collected through questionnaires. The tear film break-up time (TBUT), fluoreciin staining of conjunctiva, tear secretion test (SchirmerⅠ), infrared photography of eyelid gland, tear film lipid layer thickness (LLT), eyelid gland opening and secretion trait score were performed. All MGD patients were randomly divided into 70% model group and 30% checking group. According to clinical diagnosis, the results of each index diagnosis were determined positive and negative. Data was expressed in cases and percentages. Chi-square test was used for comparison between groups. The area under the curve (AUC) was used to check the diagnostic efficiency of indices for MGD through receiver operating characteristic curve (ROC) analysis. A discriminant model was established for effective indicators by Logistic regression model. Then, 30% patients with MGD and healthy controls were discriminated to verify the efficiency of the diagnostic model.

Results

In 70% model group, there were 402 (62.2%), 91 (79.8%) females in patients with MGD and healthy controls, respectively with statistically significant differences (χ2=196.189, P<0.05). In 70% model group, the number of positive results consistent with the clinical diagnosis in OSDI scores, fluoreciin staining of conjunctiva, SchirmerⅠ, loss rate of meibomian gland, LLT, eyelid gland opening and secretion trait score, TBUT were 478 (74.0%), 180 (27.9%), 492 (76.2%), 604 (93.5%), 512 (79.4%), 504 (78.0%), 575 (89.0%), and 583 (90.4%) cases, respectively with statistically significant differences (χ2=44.46, 442.54, 25.20, 17.54, 12.52, 6.91, 13.90, 1.75; P<0.05). ROC curve analysis shown that AUC value of OSDI scores, fluoreciin staining of conjunctiva, eyelid gland opening and secretion trait score, TBUT were less than 0.800 (P<0.05), while these effective indices were established by the Logistic discriminant model, such as gender (X1), OSDI (X2), fluoreciin staining of conjunctiva (X3), TBUT (X4), eyelid gland opening (X5), and secretion trait score (X6), and then AUC value was 0.800, which had better diagnostic efficiency. The formula was as follows: Y=1/(1+ e-Z), Z= -4.546+ 1.069X1 -0.020X2+ 0.286X3 -0.553X4-0.220X5+ 0.124X6. When the diagnostic model predictive value was greater than 0.196, it was defined as a positive diagnosis; the sensitivity of the diagnosis of MGD was 83.4%, and the specificity was 61.4%. In 30% checking group, the number of positive results consistent with the clinical diagnosis were 229 (82.7%) and 44 (40.6%) with non-significant difference (χ2=0.17, P>0.05). The sensitivity and specificity of the discriminant results were 82.7% and 61.4%, respectively.

Conclusions

Abnormal eyelid margin, lack of tear lipid layer, tear film instability, corneal epithelial fluorescein staining are helpful for the diagnosis of MGD. The Logistic discriminant model established based on these indicators has high sensitivity and specificity.

表1 70%模型组中睑板腺功能障碍患者和健康者各诊断指标与临床诊断灵敏度和特异度的比较[例(%)]
表2 各指标对睑板腺功能障碍的诊断价值
图1 联合判别模型工作特征曲线分析的结果
表3 睑板腺功能障碍检测指标的二分类Logistic回归分析
[1]
Nichols KK, Foulks GN, Bron AJ,et al.The international workshop on meibomian gland dysfunction: executive summary[J].Invest Ophth Vis Sci,2011,52(4):1922-1929.
[2]
Wang J, Call M, Mongan M,et al.Meibomian gland morphogenesis requires developmental eyelid closure and lid fusion[J].Ocular Surface,2017:S1542012417300150.
[3]
杜娟,梁庆丰,苏远东,等. 睑板腺功能障碍患者眼表特征性变化及其与吸烟行为关系的临床研究[J/CD].中华眼科医学杂志(电子版)20199(6): 378-384.
[4]
Miller , Kimberly L.Minimal clinically important difference for the ocular surface disease index[J].Archives of Ophthalmology,2010,128(1):94-101.
[5]
Schaumberg DA, Nichols JJ, Papas EB,et al.The international workshop on meibomian gland dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for MGD[J].Invest Ophth Vis Sci,2011,52(4):1994-2005.
[6]
Lane SS, Dubiner HB, Epstein RJ,et al.A new system, the LipiFlow, for the treatment of meibomian gland dysfunction[J].Cornea,2012,31(4):396-404.
[7]
Lin PY, Cheng CY, Hsu WM,et al.Association between symptoms and signs of dry eye among an elderly Chinese Population in Taiwan: The Shihpai eye study[J].Invest Ophth Vis Sci,2005,46(5):1593-1598.
[8]
Finis D, Schrader S, Geerling G.Meibomian gland dysfunction[J].Klinische Monatsblatter Fur Augenheilkunde,2012,229(5):506-513.
[9]
Sullivan BD, Evans JE, Dana MR,et al.Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions[J].Arch Ophthalmol,2006,124(9):1286-1292.
[10]
Lekhanont K, Rojanaporn D, Chuck RS,et al.Prevalence of dry eye in Bangkok, Thailand[J].Cornea,2006,25(10):1162-1167.
[11]
Vehof J, Kozareva D, Hysi PG,et al.Prevalence and risk factors of dry eye disease in a British female cohort[J].Br J Ophthalmol,2014,98(12):1712-1717.
[12]
Driver PJ, Lemp MA.Meibomian gland dysfunction[J].Survey of Ophthalmology,1996,40(5):343-367.
[13]
Erich K, Nadja K, Thomas M,et al.The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland[J].Invest Ophth Vis Sci,2011,52(4):1938-1978.
[14]
Mcculley JP, Dougherty JM, Deneau DG.Classification of chronic blepharitis[J].Ophthalmology,1982,89(10):1173-1180.
[15]
Den S, Shimizu K, Ikeda T.Association between meibomian gland changes and aging, sex, or tear function[J].Cornea,2006,25(6):651-655.
[16]
高妍,李春晖,王效武. 红外线睑板腺仪对睑板腺功能障碍患者综合治疗前后观察[J]. 中国实用眼科杂志201634(11): 1211-1214.
[17]
Arita R, Itoh K, Inoue K,et al.Contact lens wear is associated with decrease of meibomian glands[J].Ophthalmology,2009,116(3):379-384.
[18]
Arita R, Itoh K, Maeda S,et al.Proposed diagnostic criteria for obstructive meibomian gland dysfunction[J].Ophthalmology,2009,116(11):2058-2063.
[19]
Arita R, Itoh K, Maeda S,et al.Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye[J].Japanese Journal of Ophthalmology,2010,54(5):387-391.
[20]
Arita R, Minoura I, Morishige N,et al.Development of definitive and reliable grading scales for meibomian gland dysfunction[J].Am J Ophthalmol,2016,169:125-137.
[21]
Authors N.Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Work Shop (2007)[J].Ocular Surface,2007,5(2):108-152.
[22]
乔静,晏晓明. 睑板腺脂质研究进展[J]. 中华眼科杂志201248(12): 1141-1145.
[23]
徐建江,杨宇婧. 睑板腺功能障碍的临床诊断技术[J]. 中华眼科杂志201450(4): 313-317.
[24]
石常宏. 中国眼科门诊干眼的流行病学调查及干眼诊断问卷临床使用价值分析[D]. 上海:复旦大学,2014.
[25]
邱伟强,刘子源,汲婧,等. 普通眼科门诊患者干眼认知度的调查[J].中华眼科杂志201349(3): 230-234.
[26]
亚洲干眼协会中国分会,海峡两岸医药交流协会眼科专业委员会眼表与泪液病学组. 我国睑板腺功能障碍诊断与治疗专家共识(2017年)[J].中华眼科杂志201753(9): 657-661.
[27]
Nichols , Kelly K, Mitchell GL,et al.The repeatability of clinical measurements of dry eye[J].Cornea,2004,23(3):272-285.
[28]
Brismar J.Understanding receiver-operating-characteristic curves: A Graphic Approach[J].American Journal of Roentgenology,1991,157(5):1119-1121.
[29]
邹莉玲,余小金,闵捷,等. ROC曲线在医学诊断中的应用与进展[J]. 东南大学学报:医学版200322(1): 67-70.
[30]
Tortolero L, Richards K, Follen A.Comparison of C/B ratios from studies using receiver operating characteristic curve analysis——The use of ROC curves and their analyses[J].J Clin Epidemiol,1999,52(9):885-892.
[31]
Authors N.Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international dry eye Work Shop (2007)[J].Ocul Surf,2007,5(2):108-152.
[32]
Finis D, Pischel N, Schrader S,et al.Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction[J].Cornea,2013,32(12):1549-1553.
[33]
Won JJ, Yoon PS, Sun KJ,et al.Analysis of factors associated with the tear film lipid layer thickness in normal eyes and patients with dry eye syndrome[J].Investigative Ophthalmology & Visual Science,2016,57(10):4076.
[34]
董雪青,高莹莹,曾明范,等. 气相色谱-质谱法分析睑板腺功能障碍患者睑脂成分[J]. 中华眼科杂志201551(9): 668-672.
[1] 袁嘉玲, 段瑞岐, 郄明蓉. 应用受试者工作特征曲线分析人附睾蛋白4和糖链抗原-125联合检测对卵巢癌的诊断价值[J]. 中华妇幼临床医学杂志(电子版), 2012, 08(02): 155-158.
[2] 宁刚, 曲海波, 刘关键, 吴康敏, 谢蜀祥, 陈锡建. TW法在女性患儿特发性性早熟尺桡骨和手短骨骨龄评价的诊断性试验研究[J]. 中华妇幼临床医学杂志(电子版), 2008, 04(05): 420-425.
[3] 张艳兰, 徐琳, 王彩英, 庞琳. 淋巴细胞亚群在儿童重症甲型流感诊断中的价值[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(06): 368-373.
[4] 刘蜜, 向田, 李叶静, 朱焦. 血液miRNA-548ah在慢性乙型肝炎病毒感染不同时期的表达及其临床价值[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(05): 337-343.
[5] 韦振宇, 郑攀攀, 陈前坤, 梁庆丰. 角膜神经分布情况与睑板腺功能障碍患者眼表炎症相关性的临床研究[J]. 中华眼科医学杂志(电子版), 2021, 11(04): 205-210.
[6] 杜娟, 梁庆丰, 苏远东, 郑攀攀, 苏冠羽, 彭晓霞. 睑板腺功能障碍患者眼表特征性变化及其与吸烟行为关系的临床研究[J]. 中华眼科医学杂志(电子版), 2019, 09(06): 378-384.
[7] 刘秀丽, 梁倩文, 栾艺, 何川疆, 胡慧灵, 段朝晖. RDW、MCV、MCH联合筛查区分缺铁性贫血和地中海贫血携带者的应用价值[J]. 中华临床实验室管理电子杂志, 2022, 10(04): 199-203.
阅读次数
全文


摘要